Latest News and Press Releases

San Francisco, Oct. 09, 2020 (GLOBE NEWSWIRE) -- The National AIDS Memorial is announcing a virtual exhibition of the AIDS Memorial Quilt (the Quilt) that will feature more than 10,000 Quilt panels...

Milwaukee, June 23, 2020 (GLOBE NEWSWIRE) -- Vivent Health announced today a long-term partnership with the National AIDS Memorial, a nonprofit devoted to the remembrance of people lost to AIDS that...

San Francisco, Oct. 24, 2019 (GLOBE NEWSWIRE) -- The Pedro Zamora Young Leaders Scholarship, a program of the National AIDS Memorial, has awarded ten undergraduate students a total of $50,000 in...

ORLANDO, Fla., May 31, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable,...

In a release issued under the same headline earlier today by Immune Therapeutics, Inc. (OTCQB:IMUN), the headline has been corrected to read "Immune Therapeutics Announces NAFDAC Approval...

Highlights: National Agency for Food and Drug Administration and Control (“NAFDAC”) approval paves way for Immune Therapeutics’ first significant revenue channel Immune Therapeutics’ goal to capture...

ORLANDO, Fla., March 30, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics Inc. (OTCQB:IMUN), a clinical-stage biopharmaceutical company developing therapies for a range of conditions using LodonalTM,...

Immune Therapeutics Receives Approval for Lodonal™ from theDominican Republic’s Ministry of Health and Social Assistance ORLANDO, Fla., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Immune Therapeutics,...

Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...

Company Expects to Report Initial Revenues in First Half of 2017 and Achieve Profitability by Year-End Company to Host Investor Conference Call to Discuss Positive Developments ORLANDO, Fla.,...